Alcohol-associated Liver Disease

• CLINICAL_TRIALS trial_result · 2026-03-20
  Clinical Trial Update: RESTORE TRIAL: A Phase 2 Study Evaluating the Efficacy and Safety of Pemvidutide in the Treatment of Alcohol-Associated Liver Disease (ALD) [Phase 2]

  A Phase 2 clinical trial evaluating the efficacy and safety of Pemvidutide for alcohol-associated liver disease is currently recruiting.

• CLINICAL_TRIALS trial_result · 2026-01-14
  Clinical Trial Update: Safety, Tolerability, and Bioeffects of Alirocumab in Non-treatment Seeking Heavy Drinkers [Phase 1]

  Phase 1 clinical trial update on Alirocumab testing safety, tolerability, and bioeffects in non-treatment seeking heavy drinkers; study is c…

• CLINICAL_TRIALS trial_result · 2025-12-16
  Clinical Trial Update: A Cross-sectional Study on the Association of Peptidoglycan Fragments Derived From Gut Microbiota With Alcohol Liver Disease

  This completed cross-sectional study from Zhujiang Hospital investigates the association between gut microbiota–derived peptidoglycan fragme…